Soares-da Silva, P., and M. P. Serrã o. Molecular modulation of inward and outward apical transporters of L-dopa in LLC-PK 1 cells. Am J Physiol Renal Physiol 279: F736-F746, 2000.-The present study examined the nature of the apical inward and outward L-3,4-dihydroxyphenylalanine (L-dopa) transporters in LLC-PK 1 cells and whether protein kinases differentially modulate the activities of these transporters. The apical inward transfer of L-dopa was promoted through an energy-dependent and sodium-insensitive transporter (Michaelis constant ϭ 38 M; maximum velocity ϭ 2608 pmol ⅐ mg protein Ϫ1 ⅐ 6 min Ϫ1 ). This transporter was insensitive to N-(methylamino)-isobutyric acid but competitively inhibited by 2-aminobicyclo(2,2,1)-heptane-2-carboxylic acid (BHC; IC 50 ϭ 251 M). Modulators of protein kinase A (cAMP, forskolin, IBMX, and cholera toxin), protein kinase G (cGMP, zaprinast, LY-83583 and sodium nitroprusside), and protein kinase C (phorbol 12,13-dibutirate and chelerythrine) failed to affect the accumulation of L-dopa. The Ca 2ϩ /calmodulin inhibitors calmidazolium and trifluoperazine inhibited L-dopa uptake (IC 50 of 72 and 55 M, respectively). The inhibitory effect of calmidazolium on the accumulation of L-dopa was of the noncompetitive type. The organic anion inhibitor DIDS, but not p-aminohippurate, and the protein tyrosine kinase (PTK) inhibitor genistein significantly increased L-dopa accumulation, which was mainly due to inhibition of apical outward transfer of L-dopa. It is concluded that LLC-PK 1 cells take up L-dopa over the apical cell border through the L-type amino acid transporter, which appears to be under the control of Ca 2ϩ -calmodulin-mediated pathways. The apical outward transfer of L-dopa may be promoted through a DIDS-sensitive transport mechanism and appears to be under the tonic control of PTK.
L-3,4-dihydroxyphenylalanine; L-type amino acid transporter; 4,4Ј-diisothiocynatostilbene-2,2Ј-disulfonic acid-sensitive transporter; Ca 2ϩ /calmodulin; protein tyrosine kinase THE RENAL DOPAMINERGIC SYSTEM is a local nonneuronal system constituted by epithelial cells of proximal convoluted renal tubules rich in aromatic L-amino acid decarboxylase (AADC) activity and using circulating or filtered L-3,4-dihydroxyphenylalanine (L-dopa) as a source for dopamine (19, 22, 31) . Because the dopamine produced in this area is in close proximity to renal cells that contain receptors for the amine, it has been hypothesized that the amine may act as a paracrine or autocrine substance (30) . To overcome technical problems related to the handling of freshly isolated renal tubular epithelial cells, LLC-PK 1 cells, which express proximal tubule cell-like properties in vitro (17) , have been used to study dopamine receptors and the renal actions of the amine. These cells have been also shown to contain AADC and convert L-dopa to dopamine in a nonsaturable fashion up to 1 mM L-dopa (5, 11, 12) . Newly formed dopamine also stimulated cAMP accumulation in LLC-PK 1 , and this effect was attenuated by an equimolar concentration of carbidopa and blocked by the D 1 -antagonist Sch-23390 (12) . It appears, therefore, that in LLC-PK 1 cells, as in epithelial cells of proximal tubules, locally formed dopamine can act as an autocrine-paracrine substance.
Although the kidney is endowed with one of the highest levels of AADC in the body and plasma levels of L-dopa are in the nanomoles per milliliter range (13, 36) , the rate-limiting step for the synthesis of dopamine in renal tissues is still a matter of debate. However, because Michaelis constant (K m ) values for L-dopa uptake are 10 times lower than K m values for decarboxylation of L-dopa, it could be possible that L-dopa uptake rather than decarboxylation may limit the rate of formation of dopamine. In a previous report (38) , we have concluded that LLC-PK 1 cells take up L-dopa through a saturable, stereoselective, and temperaturedependent process when applied from the apical and basolateral cell border, this being similar to that occurring in rat renal proximal tubules (26, 34) . In several epithelia and at the level of brain capillary endothelium, L-dopa and other large neutral amino acids are transported by the L-type amino acid transporter. This is a sodium-independent and 2-aminobicyclo(2,2,1)-heptane-2-carboxylic acid (BHC)-sensitive transporter. Differentiation between A-and L-type transporters is based on sodium dependence and sensitivity to N-(methylamino)-isobutyric acid (MeAIB) and insensitivity to BHC; the B o,ϩ -type is BHC-sensitive and sodiumdependent transporter (1, 25, 28, 41) .
The present study examined the effect of maneuvers that affect cellular sodium and proton gradients and the sensitivity to inhibitors of amino acid transport and inhibitors of organic cation and anion transporters to define the nature of the transporters involved in the apical inward and outward transfer of L-dopa. The result of maneuvers that affect molecular mechanisms, namely those concerning protein kinase A (PKA)-, protein kinase C (PKC)-, protein kinase G (PKG)-, Ca 2ϩ / calmodulin-, and protein tyrosine kinase (PTK)-mediated pathways on L-dopa uptake, was also evaluated. It is reported that LLC-PK 1 cells take up L-dopa over the apical cell border through the L-type amino acid transporter, which appears to be under the control of Ca 2ϩ / calmodulin-mediated pathways. The apical outward transfer of L-dopa is promoted through a DIDS-sensitive transport mechanism and appears to be under the tonic control of PTK.
METHODS
Cell culture. LLC-PK 1 cells, a porcine-derived proximal renal tubule epithelial cell line that retains several properties of proximal tubular epithelial cells in culture (17) , were obtained from the American Type Culture Collection (Rockville, MD). LLC-PK 1 cells (ATCC CRL 1392; passages 198-206) were maintained in a humidified atmosphere of 5% CO 2 -95% air at 37°C and grown in Medium 199 (Sigma, St. Louis, MO) supplemented with 100 U/ml penicillin G, 0.25 g/ml amphotericin B, 100 g/ml treptomycin (Sigma), 3% fetal bovine serum (Sigma), and 25 mM HEPES (Sigma). For subculturing, the cells were dissociated with 0.05% trypsin-EDTA, split 1:4, and subcultured in Costar flasks with 75-or 162-cm 2 growth areas (Costar, Badhoevedorp, The Netherlands). For uptake studies, the cells were seeded in collagen-treated 24-well plastic culture clusters (internal diameter 16 mm, Costar) at a density of 40,000 cells/well or onto collagen-treated 0.2-m polycarbonate filter supports (internal diameter 12 mm Transwell, Costar) at a density 13,000 cells per well (2.0 ϫ 10 4 cells cm 2 ). The cell medium was changed every 2 days, and the cells reached confluence after 3-5 days of incubation. For 24 h before each experiment, the cell medium was free of fetal bovine serum. Experiments were generally performed 2-3 days after cells reached confluence and 6-8 days after the initial seeding and each squared centimeter contained ϳ80 g of cell protein.
Transport studies. On the day of the experiment, the growth medium was aspirated and the cells were washed with Hanks' medium; thereafter, the cell monolayers were preincubated for 30 min in Hanks' medium at 37°C. The Hanks' medium had the following composition (mM): 137 NaCl, 5 KCl, 0.8 MgSO 4 , 0.33 Na 2 HPO 4 , 0.44 KH 2 PO 4 , 0.25 CaCl 2 , 1.0 MgCl 2 , 0.15 Tris ⅐ HCl, and 1.0 sodium butyrate, pH ϭ 7.4. The incubation medium also contained benserazide (50 M) and tolcapone (1 M) to inhibit the enzymes AADC and catechol-O-methyltransferase, respectively. Time-course studies were performed in experiments in which cells were incubated with 0.5 M substrate for 1, 3, 6, and 12 min. Saturation experiments were performed in cells incubated for 6 min with increasing concentrations of L-dopa (10-250 M) . In experiments performed in the presence of different concentrations of sodium, NaCl was replaced by an equimolar concentration of choline chloride. Test substances were applied from the apical side only and were present during the preincubation and incubation periods. During preincubation and incubation, the cells were continuously shaken and maintained at 37°C. Apical uptake was initiated by the addition of 2 ml Hanks' medium with a given concentration of the substrate. Uptake was terminated by the rapid removal of uptake solution by means of a vacuum pump connected to a Pasteur pipette followed by a rapid wash with cold Hanks' medium and the addition of 250 l of 0.2 mM perchloric acid. The acidified samples were stored at 4°C before injection into the high-pressure liquid chromatograph for the assay of L-dopa.
Previous studies have shown that some of the L-dopa accumulated in LLC-PK 1 cells can leave the cell through apical outward transporter(s) (38) , the inhibition of which leads to an increase in the cellular accumulation of L-dopa (39) . Thus in experiments designed to study the effect of drugs that increased the intracellular accumulation of L-dopa, cells were incubated with 25 M L-dopa applied from the basal cell border and uptake (accumulation in the cell monolayer) and flux (transfer to opposite chamber) were measured over a 6-min period. Test drugs were applied from the apical side only and were present during the preincubation and incubation periods. 14 C]sorbitol in the basal chamber. At the end of incubation, cells were placed on ice and the medium bathing the apical cell border was collected, acidified with perchloric acid, and stored at 4°C till assayed for L-dopa. The cells were washed with ice-cold Hanks' medium and added with 0.2 mM perchloric acid (100 and 500 l in the upper and lower chambers, respectively); the acidified samples were stored at 4°C before injection into the high-pressure liquid chromatograph for the assay of L-dopa.
Assay of L-dopa. L-dopa was quantified by means of highpressure liquid chromatography with electrochemical detection, as previously reported (38) . The high-pressure liquid chromatograph system consisted of a pump (Gilson model 302; Gilson Medical Electronics, Villiers le Bel, France) connected to a manometric module (Gilson model 802 C) and a stainless-steel 5-m ODS column (Biophase; Bioanalytical Systems, West Lafayette, IN) of 25 cm in length; samples were injected by means of an automatic sample injector (Gilson model 231) connected to a Gilson dilutor (model 401). The mobile phase was a degassed solution of citric acid (0.1 mM), sodium octylsulphate (0.5 mM), sodium acetate (0.1 M), EDTA (0.17 mM), dibutylamine (1 mM), and methanol (8% vol/vol), adjusted to pH 3.5 with perchloric acid (2 M) and pumped at a rate of 1.0 ml/min. The detection was carried out electrochemically with a glassy carbon electrode, an Ag/AgCl reference electrode, and an amperometric detector (Gilson model 141); the detector cell was operated at 0.75 V. The current produced was monitored using the Gilson 712 HPLC software. The lower limits for detection of L-dopa ranged from 350 to 500 fmol. For the measurement of transepithelial transport, the medium in the other side was collected after incubation for the specified period of time, and the radioactivity was counted. In time course studies, an aliquot of the medium (100 l) was collected every 15 min over a period of 60 min, and the aliquot was replaced with an equal volume of Hanks' medium. The data at 30, 45, and 60 min represent cumulative values. The monolayers were agitated every 5 min during transport measurement. In some experiments, cell mono-layers were incubated in the presence of unlabeled PAH (1 mM) added from the basal side. At the end of the transport experiment, the medium was immediately aspirated and the filter was washed three times with ice-cold Hanks' medium. Subsequently, the cells were solubilized by 0.1% vol/vol Triton X-100 (dissolved in 5 mM Tris ⅐ HCl, pH 7.4) and radioactivity was measured by liquid scintillation counting.
P-glycoprotein activity. P-glycoprotein activity was measured according to the procedure described by Holló et al. (15) , with minor modifications. In brief, LLC-PK 1 cells cultured in collagen-treated cover slips were incubated in culture medium for 30 min in the absence or the presence of verapamil (25 M) and genistein (100 M). Thereafter, the cells were transferred to a Perkin-Elmer cuvette holder (model LS 50) and incubated with Hanks' medium containing 0.5 M calcein acetoxymethyl ester (calcein-AM) for a further 5 min at 37°C with continuous stirring. The Hanks' medium had the following composition (mM): 137 NaCl , 5 KCl, 0.8 MgSO 4 , 0.33 Na 2 HPO 4 , 0.44 KH 2 PO 4 , 0.25 CaCl 2 , 1.0 MgCl 2 ,0.15 Tris ⅐ HCl, and 1.0 sodium butyrate, pH ϭ 7.4. Calcein-AM is highly lipid soluble and rapidly penetrates the plasma membrane and is practically nonfluorescent. By cleavage of the ester bonds, intracellular esterases transform the dye to a hydrophilic and intensely fluorescent free acid form. Fluorescence was measured in a FluoroMax-2 (Jobin Yvon-SPEX, Edison, NJ) spectrofluorometer using excitation and emission wavelenghts of 450 and 507 nm, respectively. Time-resolved experiments were started 5 min after the addition of calcein-AM to the medium bathing the cells and lasted for 20 min. In experiments using cells pretreated with verapamil and genistein, the incubation medium also contained verapamil (25 M) or genistein (100 M). Calibration of dye concentration was based on the measurements of free calcein fluorescence in the same instrument under identical conditions (in the absence and in the presence of verapamil or genistein). All experiments were repeated five to seven times with different batches of cell monolayers.
Protein assay. The protein content of monolayers of LLC-PK 1 cells was determined by the method of Bradford (2), with human serum albumin as a standard.
Cell viability. Cells cultured in collagen-treated plastic supports were preincubated for 15 min at 37°C and then incubated in the absence or the presence of L-dopa and test compounds for further 6 min. Subsequently the cells were incubated at 37°C for 2 min with trypan blue (0.2% wt/vol) in phosphate buffer. Incubation was stopped by rinsing the cells twice with Hanks' medium, and the cells were examined using a Leica microscope. Under these conditions, Ͼ95% of the cells excluded the dye.
Data analysis. K m and maximum velocity (V max ) values for the uptake of L-dopa, as determined in saturation experiments were calculated from nonlinear regression analysis using the GraphPad Prism statistics software package (24) . P-glycoprotein activity was determined by the slope of the accumulation of calcein (in pmol/mg protein) measured by linear regression analysis (24) . Arithmetic means are given with SE. Statistical analysis was performed by one-way ANOVA followed by Newman-Keuls test for multiple comparisons. A P value less than 0.05 was assumed to denote a significant difference.
Drugs. Actinomycin D, amiloride hydrochloride, BHC, amphotericin B, calmidazolium, chelerythrine chloride, cholera toxin, cycloheximide, 
RESULTS
The accumulation of a nonsaturating concentration (0.5 M) of L-dopa, in time-course experiments, increased linearly with time for several minutes (Fig.  1A) . At 6 min when uptake was linear and considering intracellular water as 7.0 Ϯ 0.7 l/mg protein (38) , the intracellular L-dopa concentration was 4.0 Ϯ 0.4 M at medium concentration of 0.5 M. This represented a cell concentration of L-dopa that was 8.0 Ϯ 0.8 times higher than the corresponding medium concentration. In a subsequent set of experiments, designed to determine the kinetic parameters of the L-dopa apical transporter, the cells were incubated for 6 min with increasing concentrations (1 to 250 M) of the substrate (Fig.  1B) . Nonlinear analysis of the saturation curve for L-dopa revealed a K m value (in M) of 47 Ϯ 8 and a V max value (in pmol ⅐ mg protein Ϫ1 ⅐ 6 min
Ϫ1
) of 3,069 Ϯ 224.
To evaluate the metabolic requirements for L-dopa uptake, cells were pretreated with the uncoupling agent 2,4-dinitrophenol or incubated at 4°C. Pretreatment with 2,4-dinitrophenol (1 mM) resulted in a marked reduction in L-dopa (2.5 M) uptake (Table 1) . Similarly, the effect of reducing temperature from 37°C to 4°C during preincubation and incubation was a marked reduction in L-dopa (2.5 M) accumulation (Table 1) . Reducing extracellular sodium (from 140 mM to 70, 35 and 0 mM) did not affect the accumulation of L-dopa ( Fig. 2A) . Moreover, in the absence of extracellular sodium (replaced by an equimolar concentration of choline), K m and V max values for L-dopa were similar to those observed in the presence of sodium ( Table 2 ). Maneuvers that affect transepithelial flux of sodium, such as acidification of the extracellular milieu (from pH 7.4 to pH 6.9 or pH 6.4) and the addition of amphotericin B (2.5 g/ml), amiloride (100 M), or ouabain (500 M), failed to affect the accumulation of L-dopa (Table 1) . MeAIB (1 mM) failed to affect the uptake of L-dopa, whereas BHC produced a concentration-dependent inhibition of L-dopa uptake (IC 50 ϭ 251 Ϯ 26 M) (Fig. 2B) . The inhibitory effect of 1 mM BHC on the accumulation of L-dopa was of the competitive type, as evidenced by the increase in K m but not V max values for L-dopa uptake (Table 2) . Taken together, these results suggest that the apical inward transfer of L-dopa may be promoted through the BHC-sensitive and sodiumindependent L-type amino acid transporter.
Separate experiments were designed to evaluate whether the presence of a saturating concentration of (Table 2) .
Because neither the affinity nor the number of transport units was affected by prolonged exposure to a saturating concentration of L-dopa, we were then interested to know to which extent inhibition of synthesis of new transporter units would affect the uptake of L-dopa. For this purpose, confluent monolayers were exposed for 3 h to the DNA transcription inhibitor actinomycin D (0.5 g/ml) and the protein synthesis inhibitor cycloheximide (70 M) in FBS-free growth medium. Then the cells were allowed to recover for 12 h or 24 h in FBS-free growth medium before L-dopa uptake experiments took place. As shown in Fig. 3 , exposure to both actinomycin D and cycloheximide was found to significantly reduce the ability of LLC-PK 1 cells to accumulate L-dopa (2.5 M). The decrease in the ability to take up L-dopa was proportional to the extent of the interval between exposure to actinomycin D and cycloheximide and the incubation with L-dopa. The microscopic appearance of vehicle (0.1% DMSO)-treated cells was similar to those exposed to actinomycin D or cycloheximide. Thus the more intense effect of actinomycin D at 24 h than at 12 h may be not related to unspecific toxicity, but indicates a slow rate of synthesis of transporters. Though less evident, the effects of cycloheximide point in the same direction.
Though L-dopa exists as a Zwitteron, it was decided to test the effects of decynium 24 and DIDS, inhibitors of the organic cation and organic anion transporters, respectively. Decynium 24 failed to affect the accumulation of L-dopa, whereas DIDS produced a concentration-dependent increase in the accumulation of a nonsaturating concentration (2.5 M) of L-dopa (Fig. 4) . As shown in Table 2 , pretreatment of cells with 1 mM DIDS was found to markedly increase (P Ͻ 0.05) the accumulation of increasing concentrations of L-dopa without changes in K m values. In contrast, the organic anion PAH was found to produce a slight (P ϭ 0.09) decrease (ϳ20% reduction) in the accumulation of L-dopa (Fig. 4) . Though DIDS is a well-known inhibitor of the organic anion transporter (16) , it is unlikely that its effects upon L-dopa uptake might be attributed to the interference with this transporter. First, this cell line has been shown by several groups to have lost the organic anion transporter (16, 23, 27) . Second, movement of organic anions is usually performed in the opposite direction (basal-to-apical) to that imposed here for L-dopa. On the other hand, it is difficult to conceive a model in which DIDS promotes the entry of L-dopa into the cell through the apical cell border. By contrast, previous studies have shown that LLC-PK 1 cells are able to extrude L-dopa through apical outward transporter(s) (38) , the inhibition of which leads to an increase in the cellular accumulation of L-dopa (39) . Thus to clarify these issues it was decided to evaluate whether DIDS decreases the basal-to-apical flux of L-dopa, and second if LLC-PK 1 cells are endowed with the organic anion transporter. Cells cultured in polycarbonate filters were incubated with L-dopa (25 M) applied from the basal cell border and the basal-toapical flux measured. As shown in These two sets of experiments indicate that LLC-PK 1 cells were devoid of the organic anion transporter, and the increase in L-dopa accumulation by DIDS depended on its ability to reduce the outward transfer of L-dopa through the apical cell border but was unrelated to its properties as organic anion inhibitor.
Up to this stage, the combined results revealed that in LLC-PK 1 cells the apical inward transfer of L-dopa was promoted through the L-type amino acid transporter and intracellular L-dopa could be extruded by a DIDS-sensitive apical transporter that lacked the properties of an organic anion transporter. The next series of experiments explored the role of intracellular regulatory pathways in the cellular handling of L-dopa applied from the apical cell border. Involvement of a PKA-mediated pathway in the regulation of L-dopa uptake was tested by examining the effect of pretreating LLC-PK 1 cells for 30 min with compounds that are known to increase intracellular cAMP levels. Dibutyryl cAMP (0.5 mM), forskolin (50 M), IBMX (0.1 mM), and cholera toxin (5 g/ml) failed to affect the accumulation of a nonsaturating concentration of L-dopa (Table 1). In another series of experiments, we tested the involvement of a PKG-mediated pathway in the regulation of L-dopa uptake. cGMP (1 mM), zaprinast (30 M), LY-83583 (30 M), and sodium nitroprusside (100 M) failed to affect the accumulation of L-dopa ( Table 1 ). The possible role of PKC in the regulation of L-dopa uptake in LLC-PK 1 cells was tested by examining the effect of pretreating cells with either PKC activators or inhibitors. The PKC activator (1 M), the inactive phorbol ester PDDC (1 M), and the PKC inhibitor chelerythrine (50 M) were found to fail to affect the accumulation of L-dopa (Table 1) .
In another study, we tested the involvement of PTK in the regulation of L-dopa uptake by LLC-PK 1 cells. The PTK inhibitors genistein and tyrphostin 25 were found to increase the accumulation of L-dopa (2.5 M), whereas their negative controls genistin and tyrphostin 1 were devoid of effect (Fig. 7) . At the highest concentrations (300 M), genistein and tyrphostin 25 significantly (P Ͻ 0.05) increased L-dopa accumulation by 112 Ϯ 23% and 37 Ϯ 4%, respectively. As shown in Table 2 , pretreatment of cells with 300 M genistein was found to significantly increase (P Ͻ 0.05) the maximal accumulation (V max ) of increasing concentrations of L-dopa without significant changes in K m values. To test whether the increased accumulation of L-dopa-induced by genistein was due to a reduced outward transfer of intracellular (recently accumulated) L-dopa, cells cultured in polycarbonate filters were incubated with L-dopa (25 M) applied from the basal cell border and the basal-to-apical flux measured. As shown in Fig. 8 , genistein (100 M) markedly reduced the basal-to-apical flux of L-dopa and increased the accumulation of L-dopa in the cell, suggesting that PTK may be tonically active in promoting the phosphorylation of the L-dopa outward transfer. Because P-glycoprotein is one of the transporters involved in the apical outward transfer of L-dopa, it was felt worthwhile to evaluate the effect of genistein upon P-glycoprotein activity in LLC-PK 1 cells. P-glycoprotein activity was measured according to the procedure described by Holló et al. (15) , using calcein as substrate for Pglycoprotein. Figure 9 shows the accumulation of calcein in LLC-PK 1 cells in control conditions and in the presence of verapamil (25 M) or genistein (100 M) during a 20-min incubation period. As can be observed in this figure, the P-glycoprotein inhibitor verapamil, but not genistein, markedly (P Ͻ 0.05) increased the rate of accumulation of calcein. The lack of effect of genistein on calcein accumulation suggests that the increased accumulation of L-dopa by genistein may be not related to inhibition of P-glycoprotein activity.
In the final series of experiments, the role of Ca 2ϩ / calmodulin-mediated pathways in the regulation of L-dopa by LLC-PK 1 cells was tested by examining the (Fig. 10) . The inhibitory effect of 30 M calmidazolium on the accumulation of L-dopa was of the noncompetitive type, as evidenced by the decrease in V max without changes in K m values for L-dopa uptake (Table 2) .
DISCUSSION
The results presented here show that LLC-PK 1 cells transport L-dopa quite efficiently through the apical cell border, and several findings demonstrate that this uptake process is a facilitated mechanism. First, steady-state uptake of nonsaturating concentrations of L-dopa showed a linear dependence on incubation time. The efficiency of the L-dopa transport in LLC-PK 1 cells can be also evidenced by the ratio of L-dopa concentration in cellular water to medium concentration. The intracellular L-dopa concentration at 6 min, when uptake was linear, was eight times greater than that which could be expected by passive equilibration of L-dopa. Second, at 6 min of incubation the cellular transport of L-dopa showed a curvilinear dependence on substrate medium concentration, suggesting that the uptake was saturable. Thirdly, both low temperature and the uncoupling agent 2,4-dinitrophenol markedly inhibited the uptake of L-dopa. Finally, inhibition of synthesis of new transporter units by the DNA transcription inhibitor actinomycin D and the protein synthesis inhibitor cycloheximide significantly reduced the ability of LLC-PK 1 cells to accumulate L-dopa.
The sensitivity of L-dopa uptake to BHC, but not to MeAIB, supports the view that L-dopa inward transfer in LLC-PK 1 cells is promoted neither by the A-nor the ASC-type amino acid transporter, but most probably by the L-type amino acid transporter. Other evidence agreeing with this suggestion is that sodium in the incubation appeared to play no role in L-dopa uptake, as indicated by the lack of effect of sodium removal on uptake. Moreover, maneuvers that alter sodium gradients, such as those resulting from the application of amiloride (an inhibitor of the Na ϩ /H ϩ exchanger), ouabain (an inhibitor of the Na ϩ -K ϩ -ATPase), and amphotericin B (a sodium ionophore), or changes in extracellular pH, were found not to alter L-dopa uptake. The L-type, leucine preferring, amino acid transporter is facilitative, sodium independent, and blocked by BHC but not by MeAIB (1, 25, 28) . Another point suggesting that L-dopa in LLC-PK 1 cells is transported through the L-type amino acid transporter concerns the similarity of K m values for L-dopa uptake and IC 50 values for BHC when acting as an inhibitor for L-dopa uptake. Several findings suggest that the type of inhibition by BHC on L-dopa uptake is of the competitive type. Only K m values, but not V max values, for L-dopa uptake were changed when saturation experiments were performed in the presence of a concentration of the inhibitor equal to IC 50 values. The finding that L-dopa inward transport in LLC-PK 1 cells is promoted through the sodiuminsensitive L-type amino acid transporter contrasts with the role of sodium in the formation of renal dopamine. In fact, studies from several groups have shown that the increase in the renal delivery of sodium constitutes the most powerful stimulus for the production of renal dopamine (14, 29, 32) . Studies from our group using human and rat kidney slices also showed that L-dopa uptake is a sodium-dependent and ouabainsensitive process (33, 35) , suggesting that the sodiumdependent increase in urinary dopamine depends on enhanced uptake of L-dopa into tubular epithelial cells. More recently, we have shown that OK cells are endowed with sodium-dependent and sodium-independent L-dopa transporters (9, 10) , which is currently being investigated in more detail. Altogether, this suggests that LLC-PK 1 cells may lack or have loss the sodium-dependent transporter.
The finding that inhibition of the organic cation and the organic anion transporters by decynium 24 and DIDS, respectively, failed to reduce L-dopa accumulation indicates that these transporters are not involved in L-dopa uptake in LLC-PK 1 cells. By contrast, DIDS markedly increased L-dopa accumulation; this was a concentration-dependent effect, at the highest concentration (1 mM) resulting in an increase in V max values for L-DOPA uptake without changes in K m values (Table 1). Because in these experiments cells were cultured in plastic supports, the most likely explanation is that enhanced accumulation resulted from a reduced apical outward transfer of L-dopa. This is in agreement with findings in experiments carried out in cells cultured in polycarbonate filters, where DIDS produced a marked reduction in basal-to-apical flux of L-dopa and an increase in L-dopa accumulation.
After defining the mechanism of uptake, we then examined the regulation of L-dopa transport in LLC-PK 1 cells. We concentrated on intracellular regulatory pathways that have been shown to play an important role in the regulation of uptake of other substrates by epithelial cells (PKA-, PKG-, PKC-, Ca 2ϩ /calmodulinand PTK-mediated pathways). Using specific modulators of these pathways, we found that PKA-, PKG-and PKC-mediated pathways appear to have no role in regulating L-dopa uptake in LLC-PK 1 cells. In contrast, antagonists of Ca 2ϩ /calmodulin-mediated pathways, such as calmidazolium and trifluoperazine, caused a significant and concentration-dependent reduction in L-dopa uptake. The inhibitory effect of calmidazolium was accompanied by a marked decrease in V max values without changes in K m values, which is compatible with a noncompetitive inhibitory profile. This would suggest that calmidazolium might reduce the number of L-type amino acid transporters in the apical membrane. Similar findings were observed in a model of renal epithelial cell model, the HK-2 cells, where calmidazolium and other inhibitors of Ca 2ϩ /calmodulinmediated pathways, such as trifluoperazine and KN-62, were found to markedly reduce riboflavin accumulation (21) . In contrast to that observed for inhibitors of Ca 2ϩ /calmodulin-mediated pathways, PTK inhibitors genistein and tryphostin 25 were found to markedly increase L-dopa accumulation in LLC-PK 1 cells. This was a concentration-dependent effect, and the inactive analogs genistin and tyrphostin 1 failed to affect the accumulation of L-dopa in LLC-PK 1 cells cultured in plastic supports. When tested in cells cultured in polycarbonate filters, the effect of genistein was a marked reduction in basal-to-apical flux of L-dopa, this being accompanied by a large increase in the accumulation of L-dopa. This indicates that PTKmediated pathways do not interfere with the inward movement of L-dopa but exert a tonic stimulatory effect upon its outward transfer.
The apical outward transfer of L-dopa in LLC-PK 1 cells has been suggested to represent a powerful mechanism for the clearance of intracellular L-dopa in steady-state conditions (removing ϳ13% of intracellular L-dopa at a rate of 1.0 pmol ⅐ mg protein Ϫ1 ⅐ min Ϫ1 ; Ref. 38). However, this outward transfer of L-dopa is considerably less dynamic than the inward transfer at initial rate of uptake (3.6 pmol ⅐ mg protein Ϫ1 ⅐ min Ϫ1 ; Ref. 38) . The data presented here suggest that this outward transfer is a DIDS-sensitive mechanism and is susceptible of modulation by PTK-mediated pathways. Sensitivity of L-dopa outward transfer to DIDS would suggest the involvement of an organic anion transporter; 1) transport from the basal to the apical cell side corresponds to the secretion in renal tubules and 2) DIDS is a well-known inhibitor of the organic anion transporter (16) . However, this is quite unlikely to be the case, because this cell line has been shown by several groups to have lost the organic anion transporter (16, 23, 27) . As has been previously reported by others (16) , the basal-to-apical transport and accumulation of [ 3 H]PAH was not higher than that of [ 14 C]sorbitol, indicating that the apparent transport and accumulation represents nonspecific uptake and/or trapping. In agreement with these results is the finding that PAH failed to increase L-dopa accumulation in LLC-PK 1 cells (Fig. 4) . It is likely, therefore, that DIDS may have exerted its effects through inhibition of an apical outward transporter rather than the organic anion transporter. This would agree with the results recently reported for the apical secretion of ciprofloxacin by human intestinal Caco-2 epithelia, in which a novel DIDS-sensitive transport mechanism has been suggested to be involved (3). In addition, there is evidence in the literature showing that DIDS and probenecid block transport of several substrates in LLC-PK 1 cells (4, 6, 7, 20, 40) . The inhibitory effect of PTK inhibitors genistein and tyrphostin 25 upon the apical secretion of L-dopa may be to some extent connected to this DIDS-sensitive transport mechanism. In fact, genistein has recently been found to effectively inhibit the secretion of anionic substrates of liver canalicular multispecific organic anion transporter in Wistar rats (18) and diminish PAH uptake in S 2 segments of rabbit proximal tubules (8) . On the other hand, there is evidence suggesting that the apical outward transfer of L-dopa in LLC-PK 1 cells may be promoted in part through P-glycoprotein (37, 39) . Therefore, an alternative explanation for the inhibitory effect of genistein upon the apical secretion of L-dopa could be that resulting from inhibition of P-glycoprotein phosphorylation by PTK. Verapamil, which inhibits P-glycoprotein activity and markedly decreases secretion of L-dopa in LLC-PK 1 cells (37, 39) , was found to markedly increase calcein accumulation. However, the finding that genistein failed to affect the accumulation of calcein favors the view that modulation of L-dopa outward transfer by PTK may not involve phosphorylation of P-glycoprotein.
In conclusion, it is suggested that LLC-PK 1 cells take up L-dopa over the apical cell border through the L-type amino acid transporter, which appears to be under the control of Ca 2ϩ /calmodulin-mediated pathways. The apical outward transfer of L-dopa may be promoted through a DIDS-sensitive transport mechanism and appears to be under the tonic control of PTK, the inhibition of which leads to increases in the intracellular accumulation of L-dopa. Taken together the apical membrane in LLC-PK 1 cells is endowed with different transporters for the handling of L-dopa at its cytoplasmic and extracellular sides. The fact that all experiments were performed in conditions of AADC inhibition may not reduce the relevance of these findings, because L-dopa uptake process does not rate limit the formation of dopamine; large amounts of taken up L-dopa are not converted to dopamine (38) . On the other hand, substance that interfere with the outward transfer of L-dopa may even be beneficial to increase its availability for decarboxylation, leading to enhanced formation of dopamine.
